GB Sciences, Inc. (GBLX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 3.12 Million | 3.45 Million |
| Cost of Revenue | 624.00 | 61.66 Thousand | 70.48 Thousand | 47.35 Thousand | 4 Million | 3.24 Million |
| Gross Profit | -624.00 | -61.66 Thousand | -70.48 Thousand | -47.35 Thousand | -881.46 Thousand | 208.45 Thousand |
| Operating Expenses | 1.42 Million | 1.67 Million | 1.86 Million | 2 Million | 6.48 Million | 15.8 Million |
| Selling, General and Administrative Expenses | 1.15 Million | 1.67 Million | 1.86 Million | 2 Million | 6.48 Million | 15.8 Million |
| Research and Development Expenses | 261.55 Thousand | 490.29 | 821.32 | 352.27 | 1543.40 | 458.79 |
| Other Expenses | - | 100 Thousand | 9000.00 | -227.58 Thousand | -2.08 Million | -3.36 Million |
| Cost and Expenses | 1.42 Million | 1.67 Million | 1.86 Million | 2 Million | 10.48 Million | 19.04 Million |
| Operating Income | -1.42 Million | -1.67 Million | -1.86 Million | -2 Million | -12.01 Million | -15.59 Million |
| Interest Expense | 218.97 Thousand | 178.65 Thousand | 474.76 Thousand | 1.28 Million | 1.62 Million | 5.19 Million |
| Income Tax Expense | - | 2631.56 Billion | -1.8 Million | 1.45 Million | 86.83 Thousand | 526.14 Thousand |
| Earnings before Tax | -1.36 Million | -4.12 Million | -146.52 Thousand | -3.33 Million | -11.54 Million | -24.15 Million |
| Net Income | -1.36 Million | -2631.56 Billion | 1.65 Million | -4.78 Million | -11.63 Million | -23.65 Million |
| Earnings Per Share Basic | -0.00 | -7356.48 | 0.01 | -0.02 | -0.04 | -0.11 |
| Earnings Per Share Diluted | -0.00 | -7356.48 | 0.01 | -0.02 | -0.04 | -0.11 |
| Weighted Average Shares Outstanding | 396.72 Million | 357.72 Million | 317.62 Million | 285.19 Million | 258.45 Million | 209.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 396.72 Million | 357.72 Million | 317.62 Million | 285.19 Million | 258.45 Million | 209.53 Million |
| Gross Margin | - | - | - | - | -0.28 | 0.06 |
| EBIT Margin | - | - | - | - | -2.95 | -5.31 |
| Profit Margin | - | - | - | - | -3.73 | -6.85 |
| EBITDA | -1.41 Million | -1.61 Million | -1.79 Million | -2 Million | -5.61 Million | -16.3 Million |
| Earnings Before Tax Margin | - | - | - | - | -3.85 | -4.51 |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | 624.00 | - | - | 624.00 | 61.66 Thousand |
| Gross Profit | - | -624.00 | - | - | -624.00 | -61.66 Thousand |
| Operating Expenses | 369.88 Thousand | 1.41 Million | 234 Thousand | 551.49 Thousand | 265.12 Thousand | 1.67 Million |
| Selling, General and Administrative Expenses | 369.88 Thousand | - | 234 Thousand | 551.49 Thousand | 265.12 Thousand | - |
| Research and Development Expenses | 261.55 Thousand | - | - | - | - | - |
| Other Expenses | 369.88 Thousand | 1420.5 Billion | 85 Thousand | 160 Thousand | 75 Thousand | 100 Thousand |
| Cost and Expenses | 369.88 Thousand | 1.42 Million | 234 Thousand | 551.49 Thousand | 265.12 Thousand | 1.67 Million |
| Operating Income | -369.89 Thousand | -1.42 Million | -234 Thousand | -551.49 Thousand | -265.12 Thousand | -1.67 Million |
| Interest Expense | 97.15 Thousand | -218.97 Billion | 38.26 Thousand | 42.74 Thousand | 40.8 Thousand | 178.65 Thousand |
| Income Tax Expense | - | 278.31 Billion | 38.26 Thousand | 269.21 Thousand | 115.8 Thousand | 2631.56 Billion |
| Earnings before Tax | -467.04 Thousand | -1.36 Million | -187.27 Thousand | -434.23 Thousand | -273.12 Thousand | -4.12 Million |
| Net Income | -467.04 Thousand | -1.36 Million | -187.27 Thousand | -434.23 Thousand | -273.12 Thousand | -2631.56 Billion |
| Earnings Per Share Basic | -0.00 | - | -0.00 | -0.00 | -0.00 | - |
| Earnings Per Share Diluted | -0.00 | - | -0.00 | -0.00 | -0.00 | - |
| Weighted Average Shares Outstanding | 406.07 Million | 396.72 Million | 403.17 Million | 395.73 Million | 381.87 Million | 357.72 Million |
| Weighted Average Shares Outstanding (Diluted) | 406.07 Million | 396.72 Million | 403.17 Million | 395.73 Million | 381.87 Million | 357.72 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -369.89 Thousand | - | -149 Thousand | -391.49 Thousand | -189.49 Thousand | - |
| Earnings Before Tax Margin | - | - | - | - | - | - |
MOTILALOFS
SVRS
300326
LXCHEM
RXMD
MOREPENLAB